(Stroke. 2002;33:313.)
© 2002 American Heart Association, Inc.
Comments, Opinions, and Reviews |
From the University Department of Neurology (I.C.v.d.S., E.H.B., G.J.E.R.), and the Julius Center for Patient Oriented Research, University of Utrecht (E.B.), Utrecht, the Netherlands.
Correspondence to E.H. Brilstra, MD, University Department of Neurology, PO Box 85500, 3508 GA Utrecht, The Netherlands. E-mail E.Brilstra{at}neuro.azu.nl
| Abstract |
|---|
|
|
|---|
Methods We performed a MEDLINE search for studies published between January 1974 and May 1999 and hand-searched recent volumes of 21 journals. Two authors independently extracted data by means of a standardized data extraction form.
Results We found 35 studies reporting on 316 patients. Only 9 of the 35 studies reported on more than 5 patients; in only 9 studies (totaling 85 patients), well-defined outcome measures were used. Twenty-five studies (with 78% of all patients included in the review) reported on balloon occlusion. Complications during or in the first 24 hours after the balloon occlusion occurred in 4 of 247 patients (1.6%; 95% CI, 0.01% to 3.2%) and late ischemic complications in 5 of 148 patients (3.4%; 95% CI, 0.43% to 6.4%). Clinical follow-up was performed in 21 of 25 studies on treatment by means of balloon occlusion (148 [60%] of the 247 patients). None of the 68 patients treated by embolization with coils had a complication (0%; 95% CI, 0% to 4.3%). Of 157 aneurysms treated by balloon occlusion, 153 were completely thrombosed (97.5%; 95% CI, 95% to 100%). After coiling, 52 of 65 aneurysms (80%; 95% CI, 70% to 90%) were occluded by >90%.
Conclusions Many studies included in this review had methodological weaknesses. The available data suggest that both balloon occlusion and endosaccular coiling are reasonably safe and result in occlusion of the aneurysm in the majority of patients. However, long-term outcomes have not yet been reported.
Key Words: aneurysm balloon occlusion cavernous sinus endovascular therapy
| Introduction |
|---|
|
|
|---|
Little information exists on the natural course of intracavernous aneurysms. In 2 studies, totaling 90 patients, the risk of SAH was 0.4% per patient-year. The course of cranial neuropathy resulting from mass effect of the aneurysm was variable; symptoms often progressed but spontaneously disappeared in up to 20% of patients.1,2
Given the relatively benign course of ICAs that are strictly intracavernous and the small chance of SAH if ICAs extend through the dura, any treatment should have a low risk of complications.
Surgical treatment of ICAs is difficult because of the surrounding cavernous sinus. In the past, therapeutic options have included ligation of the internal carotid artery and direct microsurgical exposure of the cavernous aneurysm.3,4 Since 1974, ICAs have been treated by endovascular occlusion of the parent vessel with detachable balloons. In 1991, Guglielmi detachable coils for endosaccular packing of the aneurysm became available.
Many reports on endovascular treatment of intracavernous aneurysms by balloon occlusion or coiling have now been published, but a systematic review of the risks and effectiveness of the two endovascular treatment modalities is lacking.
| Materials and Methods |
|---|
|
|
|---|
Eligibility
The criteria for inclusion of studies in this review were publication after 1974 and treatment of cavernous carotid artery aneurysms by balloon occlusion of the internal carotid artery or by endosaccular occlusion with detachable coils. Studies on patients younger than 18 years, patients with mycotic, traumatic, bacterial, or dissecting aneurysms, and patients with an aneurysm associated with an arteriovenous malformation were not included. When no information was available on the type of aneurysm or on procedural complications, studies were excluded. A language other than English was not an exclusion criterion.
Data Extraction
Two investigators independently assessed eligibility of studies and extracted data by means of a standardized data extraction form. In the case of disagreement, both observers reviewed the article in question together until consensus was reached. We extracted data on (1) study design (Table 1), (2) baseline characteristics (Table 2), and (3) procedural complications, radiologic results, and clinical outcomes (Table 3). Additionally we recorded whether patients were treated by one or more radiologists and in one or more centers.
|
|
|
For patients treated by balloon occlusion of the parent vessel, we additionally recorded whether the aneurysm was completely thrombosed and if it had become smaller at follow-up MRI.
For the assessment of outcome, we extracted data on symptoms and signs of mass effect from the aneurysm and on global functional health at follow-up. We used the Rankin scale to classify functional health. We dichotomized outcome in "good outcome" (independent for activities of daily living, Rankin score 0 to 2) and "poor outcome" (dependent for activities of daily living, Rankin score 3 to 5) or deceased. In the case of poor outcome, we recorded whether this was related to the procedure.
Data Analysis
All analyses were performed separately for the two treatment modalities.
We calculated the proportion and corresponding 95% confidence intervals of all extracted variables. In addition, we assessed the proportions of patients with improved, unchanged, or worse functional health compared with the health status before treatment and the proportions of patients with improved or resolved symptoms of mass effect after treatment.
By means of weighted linear regression analyses, we quantified the association between aneurysm size, aneurysm type, clinical condition, and mean age on the one hand and the following outcome measures on the other: proportion of early permanent complications, degree of thrombosis or proportion of >90% occluded aneurysms, improved diplopia, and clinical outcome.
For patients treated by balloon occlusion of the parent artery, we additionally assessed the association between aneurysm shape (saccular or fusiform) and the aforementioned outcome measures; for patients treated with coils, we assessed the association between neck size of the aneurysm and outcome measures.
| Results |
|---|
|
|
|---|
We included 35 studies in 5 languages. Twenty-five studies (247 patients, 78% of all patients included in this review) reported on treatment by balloon occlusion of the parent vessel529 and 12 studies (68 patients, 24%) reported on endosaccular packing of the aneurysm with coils.6,27,3039 In 2 studies, authors reported on both balloon occlusion of the parent vessel and embolization with coils.
The data on study design are given in Table 1. Nine studies used well-defined outcome measures. In 5 studies, clinical outcome measures were used: the Glasgow Outcome Scale in 2 studies (3 patients), the Karnofski score in 1 study (2 patients), and the course of symptoms caused by mass effect in 2 studies (42 patients). Four studies reported on anatomic results (40 patients).
Twenty-six studies reported on treatment of <5 patients. Of the 68 patients treated with coils, 51 (75%) were derived from only 2 studies. The mean number of patients per study was 9 (median, 2 patients). One study reported on treatment by 1 radiologist (34 patients, 11%); 4 studies reported on treatment by several radiologists (111 patients, 35%). Two studies reported on patients from more than 1 hospital (41 patients, 13%).
Baseline Characteristics
Table 2 presents the baseline characteristics of patients treated by balloon occlusion of the parent vessel or by embolization with coils. No data were given on clinical condition at onset for the 16 patients who presented with SAH.
Of the 247 patients treated by balloon occlusion of the parent vessel, 5 patients had bilateral intracavernous aneurysms. In 3 patients, only the symptomatic aneurysm was treated and the asymptomatic bilateral aneurysm was left untreated. In one patient, one aneurysm was treated by occlusion of the parent vessel and the other by embolization with coils. In the fifth patient, both aneurysms were treated by balloon occlusion.
Sixty-nine patients were treated by means of embolization with coils. In one patient with bilateral intracavernous aneurysms, both aneurysms were treated with coils.
Complications, Data on Procedure, Effectiveness, and Clinical Outcome
Table 3 shows the percentages and type of complications, the radiologic results, clinical outcome, and for treatment by balloon occlusion of the parent vessel, data on the use of test occlusion and on the construction of an extracranial-intracranial (EC-IC) bypass.
Four of 247 patients (1.6%; 95% CI, 0.01% to 3.2%) treated by balloon occlusion had an early complication leading to permanent neurological deficit, and 5 of the 148 patients had a late and permanent ischemic complication (3.4%; 95% CI, 0.43% to 6.4%). Follow-up after the procedure was not available for 99 patients. There were no early or late permanent complications in patients treated by embolization with coils (0%; 95% CI, 0% to 4.3%).
An EC-IC bypass was constructed in 36 patients before balloon occlusion of the parent vessel: in 7 patients because the patient did not tolerate balloon test occlusion, in 11 patients because of presumed insufficiency of the collateral circulation, and in 2 patients as a precautionary measure. For 16 patients, the indications were not clear. It was not possible to evaluate the effect of the construction of an EC-IC bypass because data on outcome were often provided only for the entire group and not separately for the subgroup of patients with an EC-IC bypass.
Follow-up on deaths was available for almost all patients treated by endosaccular coiling; for patients treated by means of balloon occlusion, this information was lacking for half of the patients. Three patients (4.6%) treated by embolization with coils died; 1 patient who had epistaxis and was successfully treated had a series of strokes 1 month after treatment, probably caused by subacute bacterial endocarditis. He was successfully treated with antibiotics. The following month, he died of an unknown cause.31 One patient died after rupture of an additional aneurysm31 and one from secondary ischemia after SAH from another intradural aneurysm.6
Weighted Linear Regression
For treatment by balloon occlusion, weighted linear regression analyses did not show any relation that was statistically significant between aneurysm size, aneurysm type, clinical condition before treatment and mean age on the one hand and the proportion of early permanent complications, the degree of thrombosis of the aneurysm, improved diplopia, and clinical outcome on the other.
For treatment by embolization with coils, linear regression analysis showed a statistically significant inverse relation between the presence of additional aneurysms and the proportion of patients with good outcome (ßb=-0.08; 95% CI, -0.12 to -0.03). The value -0.08 indicates that for each percentage point of more patients with an additional aneurysm, the percentage of patients with good outcome decreases by 0.08%. The corresponding 95% CI implies that the data are compatible with a decrease of the percentage of patients with good outcome ranging from 0.03% to 0.12%. There was also a statistically significant association between the percentage of nongiant aneurysms and the percentage of aneurysms occluded by >90% (ßb=0.73; 95% CI, 0.47 to 0.99). Also, we found a relation between the presence of fistulas and improvement of diplopia (ßb=7.02; 95% CI, 1.71 to 12.32) and between increased age and improvement of diplopia (ßb=3.68; 95% CI, 0.71 to 6.7).
| Discussion |
|---|
|
|
|---|
Nevertheless, decisions on treatment of intracavernous aneurysms must be made, and patients need to be informed. The data presented here are presently the best available evidence. The results of our review indicate that both balloon occlusion of the parent vessel and endosaccular coiling are reasonably safe and result in occlusion of the aneurysm in the majority of patients.
Embolization with coils did not result in permanent complications, but 20% of all aneurysms were only partially occluded. We found that nongiant aneurysms were more often occluded by coils by >90% than giant aneurysms, which often have wider neck sizes than nongiant aneurysms, with increased risk of coils herniating back into the patent vessel.40 Also in a previously study, aneurysm size was a predictor for successful obliteration of the lumen, not as an independent predictor of success but more likely through its direct correlation with neck size.41
Embolization with coils is a newly developed treatment. During the period of data collection for the current review, many endovascular therapists probably still were on the steep part of the learning curve with regard to embolization with coils. With increasing experience, the clinical and radiological results are expected to improve. As yet, data on long-term follow-up are scarce and are therefore not included in this review.
Diplopia, if present before treatment, improved in nearly all patients after treatment by coiling and in 81% of patients after treatment by means of balloon occlusion. Almost all patients treated by balloon occlusion of the parent vessel had giant aneurysms.
Balloon occlusion of the parent vessel resulted in complete thrombosis in 99% of aneurysms.
The percentage of permanent, predominantly ischemic complications was 5%, in keeping with a study on stroke risk after abrupt internal carotid artery sacrifice, which reported an infarction rate ranging from 4% to 10% after balloon test occlusion with clinical tolerance as sole criterion,40,42 as was performed in the majority of patients included in this review.
Recently, a test occlusion protocol consisting of clinical observation and synchronous venous filling on angiography has proved to be reliable in predicting acute and delayed cerebral ischemia after parent artery occlusion.43 With the use of this protocol, the percentage of ischemic complications can be expected to decrease.
Publication bias may have influenced our results. Studies with good results are more likely to be submitted and accepted for publication than studies with poor results. To minimize publication bias, we included studies in all languages from all journals.
Direct clipping of intracavernous carotid aneurysms is difficult because of the surrounding structures. There is no thorough overview of results of surgical treatment of intracavernous carotid aneurysms, but in a series of 115 surgically treated patients, 3 died after surgery, 2 (with traumatic aneurysms) of associated brain injury and 1 of pulmonary embolism. Oculomotor palsy was present in the immediate postoperative period in 104 patients. However, 6 months after surgery, only 7 patients had residual palsy. Four patients had persistent residual contralateral hemiparesis.44 Because endovascular treatment is less invasive, takes less time for treatment and recovery, and has low complication rates, it has increasingly replaced surgical treatment.
When considering treatment of patients with a cavernous sinus aneurysm, the risk of permanent complications must be weighed against the natural history of these aneurysms. Because of the methodological weaknesses of many studies included in this review and the scarcity of data on the natural course of intracavernous aneurysms, a general advice for treatment is still premature.
| Acknowledgments |
|---|
Received June 21, 2001; revision received October 15, 2001; accepted October 16, 2001.
| References |
|---|
|
|
|---|
2. Kupersmith MJ, Hurst R, Berenstein A, Choi IS, Jafar J, Ransohoff J. The benign course of cavernous carotid artery aneurysms. J Neurosurg. 1992; 77: 690693.[Medline] [Order article via Infotrieve]
3. Galbraith JG, Clark RM. Role of carotid ligation in the management of intracranial carotid aneurysms. Clin Neurosurg. 1974; 21: 171181.[Medline] [Order article via Infotrieve]
4. Dolenc V. Direct microsurgical repair of intracavernous vascular lesions. J Neurosurg. 1983; 58: 824831.[Medline] [Order article via Infotrieve]
5. Higashida RT, Halbach VV, Dowd C, Barnwell SL, Dormandy B, Bell J, et al. Endovascular detachable balloon embolization therapy of cavernous carotid artery aneurysms: results in 87 cases. J Neurosurg. 1990; 72: 857863.[Medline] [Order article via Infotrieve]
6. Bavinzski G, Killer M, Ferraz-Leite H, Gruber A, Gross CE, Richling B. Endovascular therapy of idiopathic cavernous aneurysms over 11 years. AJNR Am J Neuroradiol. 1998; 19: 559565.[Abstract]
7. Mihout B, Weber J, Thiebot J, Clavier E, Creissard P, Samson M. Neuroradiologic treatment of intracavernous carotid aneurysms: apropos of 2 cases. Rev Otoneuroophtalmol. 1982; 54: 261268.[Medline] [Order article via Infotrieve]
8. Vazquez A, Aymard A, Gobin YP, Casasco A, Ruffenacht D, Khayata MH, et al. Balloon occlusion of the internal carotid artery in 40 cases of giant intracavernous aneurysm: technical aspects, cerebral monitoring, and results. Neuroradiology. 1992; 34: 245251.[CrossRef][Medline] [Order article via Infotrieve]
9. Barnett DW, Barrow DL, Joseph GJ. Combined extracranial-intracranial bypass and intraoperative balloon occlusion for the treatment of intracavernous and proximal carotid artery aneurysms. Neurosurgery. 1994; 35: 9297.[Medline] [Order article via Infotrieve]
10. Barrow DL, Spector RH, Braun IF, Landman JA, Tindall SC, Tindall GT. Classification and treatment of spontaneous carotid-cavernous sinus fistulas. J Neurosurg. 1985; 62: 248256.[Medline] [Order article via Infotrieve]
11. Braun IF, Hoffman JC, Casarella WJ, Davis PC. Use of coils for transcatheter carotid occlusion. AJNR Am J Neuroradiol. 1985; 6: 953956.[Medline] [Order article via Infotrieve]
12. Campos JG, Gomes LB, Almeida A, Coutinho D, Pereira R, Antunes JL, et al. Intravascular therapy of giant cerebral aneurysm. Acta Med Port. 1990; 3: 359366.[Medline] [Order article via Infotrieve]
13. Debrun GM, Davis KR, Nauta HJ, Heros RE, Ahn HS. Treatment of carotid cavernous fistulae or cavernous aneurysms associated with a persistent trigeminal artery: report of three cases. AJNR Am J Neuroradiol. 1988; 9: 749755.[Abstract]
14. Desal H, Leaute F, Auffray-Calvier E, Martin S, Guillon B, Robert R, et al. Direct carotid-cavernous fistula. Clinical, radiologic and therapeutic studies: apropos of 49 cases. J Neuroradiol. 1997; 24: 141154.[Medline] [Order article via Infotrieve]
15. Ferrito G, Quilici N, Gianni G, Prosetti D, Scazzeri F, Marcacci G. Balloon occlusion of the carotid artery in the treatment of cavernous giant aneurysms: two cases. Ital J Neurol Sci. 1994; 15: 423427.[Medline] [Order article via Infotrieve]
16. Ishikawa T, Nakagawa Y, Miyamachi K, Abe H, Miyasaka K, Takei H, et al. A case of internal carotid artery aneurysm of the cavernous portion treated by trapping with the detachable balloon technic. No Shinkei Geka. 1987; 15: 759763.[Medline] [Order article via Infotrieve]
17.
Kupersmith MJ, Berenstein A, Choi IS, Ransohoff J, Flamm ES. Percutaneous transvascular treatment of giant carotid aneurysms: neuro-ophthalmologic findings. Neurology. 1984; 34: 328335.
18. Kwan ES, Wolpert SM, Scott RM, Runge V. MR evaluation of neurovascular lesions after endovascular occlusion with detachable balloons. AJNR Am J Neuroradiol. 1988; 9: 523531.[Abstract]
19. Linskey ME, Sekhar LN, Horton JA, Hirsch WL, Yonas H. Aneurysms of the intracavernous carotid artery: a multidisciplinary approach to treatment. J Neurosurg. 1991; 75: 525534.[Medline] [Order article via Infotrieve]
20. Lopes DK, Mericle RA, Wakhloo AK, Guterman LR, Hopkins LN. Cavernous sinus syndrome during balloon test occlusion of the cervical internal carotid artery: report of two cases. J Neurosurg. 1998; 89: 667670.[Medline] [Order article via Infotrieve]
21. Lylyk P, Vinuela F, Campos J, Fox AJ, Pelz DM, Debrun G, et al. Diagnosis and endovascular therapy of vascular lesions in the cavernous sinus. Acta Radiol Suppl. 1986; 369: 584585.[Medline] [Order article via Infotrieve]
22. Marchal JC, Picard L, Moret J, Bracard S, Auque J, Hepner H, et al. Treatment of intracavernous carotid aneurysms by temporo-sylvian bypass combined with endovascular occlusion. J Neuroradiol. 1985; 12: 249259.[Medline] [Order article via Infotrieve]
23. Negoro M, Kageyama N, Ishiguchi T. Cerebrovascular occlusion by catheterization and embolization: clinical experience. AJNR Am J Neuroradiol. 1983; 4: 362365.[Abstract]
24. Polin RS, Shaffrey ME, Jensen ME, Braden L, Ferguson RD, Dion JE, et al. Medical management in the endovascular treatment of carotid-cavernous aneurysms. J Neurosurg. 1996; 84: 755761.[Medline] [Order article via Infotrieve]
25. Raymond J, Theron J. Intracavernous aneurysms: treatment by proximal balloon occlusion of the internal carotid artery. AJNR Am J Neuroradiol. 1986; 7: 10871092.[Abstract]
26. Serbinenko FA, Filatov JM, Spallone A, Tchurilov MV, Lazarev VA. Management of giant intracranial ICA aneurysms with combined extracranial-intracranial anastomosis and endovascular occlusion. J Neurosurg. 1990; 73: 5763.[Medline] [Order article via Infotrieve]
27. Slaba S, Smayra T, Mohasseb G, Chedid G, Aoun N, Haddad S, et al. "Mirror" intracavernous aneurysms: therapeutic dilemma apropos of a case with review of the literature. Neurochirurgie. 1997; 43: 325329.[Medline] [Order article via Infotrieve]
28. Theron J. Uncommon vascular lesions of the intracavernous carotid siphon treated by Fogarty catheters. J Neuroradiol. 1980; 7: 183191.[Medline] [Order article via Infotrieve]
29. van Rooij WJ, Sluzewski M, Wijnalda D. Balloon occlusion of the internal carotid artery in the treatment of inoperable aneurysms. Ned Tijdschr Geneeskd. 1995; 139: 10411044.[Medline] [Order article via Infotrieve]
30. Guglielmi G, Vinuela F, Dion J, Duckwiler G. Electrothrombosis of saccular aneurysms via endovascular approach, II: preliminary clinical experience. J Neurosurg. 1991; 75: 814.[Medline] [Order article via Infotrieve]
31. Halbach VV, Higashida RT, Dowd CF, Urwin RW, Balousek PA, Lempert TE, et al. Cavernous internal carotid artery aneurysms treated with electrolytically detachable coils. J Neuroophthalmol. 1997; 17: 231239.[Medline] [Order article via Infotrieve]
32. Horowitz M, Purdy P, Kopitnik T, Dutton K, Samson D. Aneurysm retreatment after Guglielmi detachable coil and nondetachable coil embolization: report of nine cases and review of the literature. Neurosurgery. 1999; 44: 712719.[CrossRef][Medline] [Order article via Infotrieve]
33. Malisch TW, Guglielmi G, Vinuela F, Duckwiler G, Gobin YP, Martin NA, et al. Intracranial aneurysms treated with the Guglielmi detachable coil: midterm clinical results in a consecutive series of 100 patients. J Neurosurg. 1997; 87: 176183.[Medline] [Order article via Infotrieve]
34. Malisch TW, Guglielmi G, Vinuela F, Duckwiler G, Gobin YP, Martin NA, et al. Unruptured aneurysms presenting with mass effect symptoms: response to endosaccular treatment with Guglielmi detachable coils, I: symptoms of cranial nerve dysfunction. J Neurosurg. 1998; 89: 956961.[CrossRef][Medline] [Order article via Infotrieve]
35. Martin D, Rodesch G, Alvarez H, Lasjaunias P. Preliminary results of embolisation of nonsurgical intracranial aneurysms with GD coils: the 1st year of their use. Neuroradiology. 1996; 38 (suppl 1): S142S150.
36. McLaughlin MR, Jho HD, Kwon Y. Acute subdural hematoma caused by a ruptured giant intracavernous aneurysm: case report. Neurosurgery. 1996; 38: 388392.[Medline] [Order article via Infotrieve]
37. Siniluoto T, Seppanen S, Kuurne T, Wikholm G, Leinonen S, Svendsen P. Transarterial embolization of a direct carotid cavernous fistula with Guglielmi detachable coils. AJNR Am J Neuroradiol. 1997; 18: 519523.[Abstract]
38. van Rooij WJ, Sluzewski M, Wijnalda D, Verhagen I, Schellens RL, op de Coul AA. Intravascular treatment of inoperable cerebral aneurysms using Guglielmis spirals; initial results in The Netherlands. Ned Tijdschr Geneeskd. 1996; 140: 491495.[Medline] [Order article via Infotrieve]
39. Yang X, Saari T, Kansanen M, Puranen M, Soimakallio S. Epistaxis from nontraumatic intracavernous carotid aneurysm: endovascular treatment with detachable coils and electrothrombosis. Am J Otolaryngol. 1995; 16: 255259.[Medline] [Order article via Infotrieve]
40.
Brilstra EH, Rinkel GJ, van der GY, van Rooij WJ, Algra A. Treatment of intracranial aneurysms by embolization with coils: a systematic review. Stroke. 1999; 30: 470476.
41.
Hope JK, Byrne JV, Molyneux AJ. Factors influencing successful angiographic occlusion of aneurysms treated by coil embolization. AJNR Am J Neuroradiol. 1999; 20: 391399.
42. Linskey ME, Jungreis CA, Yonas H, Hirsch WL, Sekhar LN, Horton JA, et al. Stroke risk after abrupt internal carotid artery sacrifice: accuracy of preoperative assessment with balloon test occlusion and stable xenon-enhanced CT. AJNR Am J Neuroradiol. 1994; 15: 829843.[Abstract]
43. van Rooij WJ, Sluzewski M, Metz NH, Nijssen PC, Wijnalda D, Rinkel GJ, et al. Carotid balloon occlusion for large and giant aneurysms: evaluation of a new test occlusion protocol. Neurosurgery. 2000; 47: 116121.[CrossRef][Medline] [Order article via Infotrieve]
44. Dolenc VV. Extradural approach to intracavernous ICA aneurysms. Acta Neurochir Suppl (Wien). 1999; 72: 99106.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
W S Lesley and R Rangaswamy Balloon test occlusion and endosurgical parent artery sacrifice for the evaluation and management of complex intracranial aneurysmal disease JNIS, December 1, 2009; 1(2): 112 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.J. van Rooij and M. Sluzewski Endovascular Treatment of Large and Giant Aneurysms AJNR Am. J. Neuroradiol., January 1, 2009; 30(1): 12 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.J. van Rooij and M. Sluzewski Unruptured Large and Giant Carotid Artery Aneurysms Presenting with Cranial Nerve Palsy: Comparison of Clinical Recovery after Selective Aneurysm Coiling and Therapeutic Carotid Artery Occlusion AJNR Am. J. Neuroradiol., May 1, 2008; 29(5): 997 - 1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-H. Li, Y.-D. Li, B.-L. Gao, C. Fang, Q.-Y. Luo, Y.-S. Cheng, Z.-Y. Xie, Y.-L. Wang, J.-G. Zhao, Y. Li, et al. A New Covered Stent Designed for Intracranial Vasculature: Application in the Management of Pseudoaneurysms of the Cranial Internal Carotid Artery AJNR Am. J. Neuroradiol., September 1, 2007; 28(8): 1579 - 1585. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.N. de Gast, M.E. Sprengers, W.J. van Rooij, C. Lavini, M. Sluzewski, and C.B. Majoie Long-Term 3T MR Angiography Follow-Up after Therapeutic Occlusion of the Internal Carotid Artery to Detect Possible de Novo Aneurysm Formation AJNR Am. J. Neuroradiol., March 1, 2007; 28(3): 508 - 510. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.B. Ross and R. Buciuc The Vascular Plug: A New Device for Parent Artery Occlusion AJNR Am. J. Neuroradiol., February 1, 2007; 28(2): 385 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Carrera, A. Salar, J. Pascual, M. Mir, J. J. Chillaron, and J. F. Cano Hypopituitarism associated with mycotic aneurysm of the cavernous carotid artery in a renal transplant recipient Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3299 - 3300. [Full Text] [PDF] |
||||
![]() |
W.J. van Rooij, M. Sluzewski, and G.N. Beute Ruptured Cavernous Sinus Aneurysms Causing Carotid Cavernous Fistula: Incidence, Clinical Presentation, Treatment, and Outcome AJNR Am. J. Neuroradiol., January 1, 2006; 27(1): 185 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Abud, L. Spelle, M. Piotin, C. Mounayer, J. R. Vanzin, and J. Moret Venous Phase Timing during Balloon Test Occlusion as a Criterion for Permanent Internal Carotid Artery Sacrifice AJNR Am. J. Neuroradiol., November 1, 2005; 26(10): 2602 - 2609. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Weber, R. Siekmann, B. Kis, and D. Kuehne Treatment and Follow-Up of 22 Unruptured Wide-Necked Intracranial Aneurysms of the Internal Carotid Artery with Onyx HD 500 AJNR Am. J. Neuroradiol., September 1, 2005; 26(8): 1909 - 1915. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. van Rooij, M. Sluzewski, M. J. Slob, and G. J. Rinkel Predictive Value of Angiographic Testing for Tolerance to Therapeutic Occlusion of the Carotid Artery AJNR Am. J. Neuroradiol., January 1, 2005; 26(1): 175 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Goldenberg-Cohen, C Curry, N R Miller, R J Tamargo, and K P J Murphy Long term visual and neurological prognosis in patients with treated and untreated cavernous sinus aneurysms J. Neurol. Neurosurg. Psychiatry, June 1, 2004; 75(6): 863 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Atri and V. Sheen Cavernous Sinus Syndrome and Headache Due to Bilateral Carotid Artery Aneurysms Arch Neurol, September 1, 2003; 60(9): 1327 - 1328. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |